Elsevier, The Lancet Global Health, Volume 10, February 2022
Background: China has the highest prevalence of hepatitis B virus (HBV) infection worldwide. Universal HBV screening might enable China to reach the WHO 2030 target of 90% diagnostics, 80% treatment, and 65% HBV-related death reduction, and eventually elimination of viral hepatitis. We evaluated the cost-effectiveness of implementing universal HBV screening in China and identified optimal screening strategies.
The Lancet Healthy Longevity, Volume 3, February 2022
Background: Air pollution might accelerate cognitive ageing; it is unclear whether large-scale interventions, such as China's Clean Air Act (CCAA), can mitigate cognitive deterioration. We aimed to evaluate the effect of CCAA on changes in cognitive function in older adults. Methods: In this population-based, quasi-experimental study, we did a difference-in-differences analysis of the data collected during the 2014 and 2018 waves of the Chinese Longitudinal Healthy Longevity Survey (CLHLS).
Elsevier,
The Lancet Planetary Health, Volume 6, February 2022
A Review in support of SDGs 3 and 12, focusing on the decrease in traditional food availability and the increase in food import dependence in small islands, discussing the resulting reduction in diet quality and food security and the increase in type 2 diabetes risk.
Elsevier,
Science of the Total Environment, Volume 806, 1 February 2022
This paper presents a literature review, describing the main research fields in agricultural land systems and their linkage with SDG 2, 3, and 15, namely the discrepancy in the percentage of publications by research field emphasizes the need for future studies to fulfil this gap because each domain has a vital role in providing knowledge to food security and the SDGs
Elsevier,
eBioMedicine, Volume 76, February 2022
This Review supports SDG 3 and 10 by highlighting how genomics research intersects with existing racial and ethnic inequalities and forms of exclusion; there is no universally accepted, consistently applied method for categorising genomic data, which the authors argue is problematic, both from a clinical and scientific perspective, but more fundamentally in terms of the ability of genomics research to achieve the core ethical values of equity and justice.
